Sci Simple

New Science Research Articles Everyday

# Biology # Immunology

Sepsis: A Hidden Fight for Recovery

Sepsis can change lives long after the infection is gone.

Marco De Zuani, Petra Lázničková, Marcela Hortová Kohoutková, Veronika Bosáková, Ivana Andrejčinová, Natália Vadovičová, Veronika Tomášková, Alexandra Mýtniková, Julie Štíchová, Tomáš Tomáš, Jiří Hrdý, Kristýna Boráková, Stjepan Uldrijan, Marcela Vlková, Vladimír Šrámek, Martin Helán, Kamila Bendíčková, Jan Frič

― 6 min read


Sepsis Recovery: The Sepsis Recovery: The Silent Battle after sepsis. Survivors face hidden challenges long
Table of Contents

Sepsis is a serious condition that occurs when the body has an extreme response to an infection. It can damage organs and can be quite deadly. You might think of it as your body's alarm system going haywire; instead of focusing on the infection, it starts attacking itself. This chaotic response can lead to organ failure, and statistics show that many people are affected by sepsis each year, with a notable percentage not making it through.

The Aftermath of Sepsis

Surviving sepsis isn't the end of the story. Many who are lucky enough to pull through often face a host of struggles down the road. These can include:

  • Increased Risk of Infections: After sepsis, the immune system can become more vulnerable and may struggle to fight off even the mildest of infections.

  • Chronic Changes in Immune Cells: The immune cells, particularly monocytes, can get "reprogrammed" after sepsis. This means that they might not function as effectively in the future.

  • Low-Grade Inflammation: Some survivors experience ongoing inflammation, which can be quite bothersome.

  • Cellular Damage: Molecules that indicate damage in the body might be released, complicating recovery even more.

How Sepsis Affects Blood Cell Production

Our blood is made up of various types of cells, including those that fight infections. These are produced in the bone marrow, which is like a factory for Blood Cells. After experiencing sepsis, the production lines can get jammed, leading to altered blood cell types and numbers.

Hematopoietic Stem Cells

At the heart of blood cell production are hematopoietic stem cells (HSCs). These are the original cells that can turn into any type of blood cell. With aging, the number of HSCs can increase, but sepsis can kick this production into overdrive, particularly for certain types of white blood cells.

What Happens During Recovery?

Following an episode of sepsis, the body undergoes changes. HSCs might become less responsive, leading to issues like what we call "HSC exhaustion." This means they’re less able to produce new blood cells efficiently. It's as if the factory workers have taken an extended vacation after working overtime during the sepsis episode!

Trained Immunity – The Good and the Bad

There's a concept called "trained immunity," which suggests that some immune cells can remember their encounters with pathogens. After sepsis, it seems that certain immune cells become "trained" but not always for the better. Instead of being ready to fight off infections, they might end up being less effective, leading to a state of confusion in the immune system.

Imagine your immune cells as soldiers who fought bravely in a battle (the initial infection). They come back and get a medal, but now they think that every little noise is a threat. This means they may overreact to things that wouldn’t normally be a problem, and this can lead to chronic inflammation.

Profiling the Immune System After Sepsis

To get a clearer picture of how sepsis messes with the immune system, researchers have compared the blood of people who survived sepsis with people who didn't have sepsis. This involved looking at the types and counts of various immune cells in the blood.

Findings from Research

  1. Circulating Progenitors: Survivors of sepsis show an increase in certain types of progenitor cells, which are the cells that will eventually develop into various blood cells. This indicates a shift in how the body is producing blood cells long after the initial infection.

  2. Decrease in Neutrophils: Neutrophils are crucial for fighting infections. In sepsis survivors, the numbers of these cells can be lower, suggesting a longer-term problem with the immune response. It's like having fewer firefighters available when a fire breaks out!

  3. Immature Immune Cells: Sepsis survivors often have an increase in immature immune cells, which are not as effective at fighting infections. This means that while the body may produce more cells, many of them are not the right type to tackle invaders.

Macrophages – The Clean-Up Crew

Macrophages are a type of immune cell that plays a key role in cleaning up debris after an infection and signaling the rest of the immune team to respond. After sepsis, the macrophages derived from HSCs show some metabolic troubles.

Metabolic Impairments

These macrophages exhibit lower activity in some important energy pathways, making them less efficient at burning fuel. They are like cars that have run low on gas and can't speed up when needed. This can hinder their ability to respond appropriately to future infections, leading to increased risk for the survivor.

Signaling Pathways and Cellular Communication

In the body, cells communicate through various pathways. Two important signaling pathways have been identified in sepsis survivors:

  1. NF-κB Pathway: This pathway is crucial for inflammatory responses. In sepsis survivors, this pathway is activated, which can lead to an overactive inflammatory response.

  2. JAK-STAT Pathway: This pathway responds to signals from immune modulators. It's been found that sepsis survivors have heightened activity here as well, further complicating their immune response.

The Role of Interferon

Interferons are proteins that play several roles in the immune response. After sepsis, specific types of interferons, like type-I interferons, can show heightened activity. This leads to changes in the immune cells that may not help but instead keep the immune system in a constant state of readiness, which can wear it out over time.

Effects of Interferon on Macrophage Development

When researchers treated healthy blood cells with interferon, they found that:

  • The number of cells decreased over time, making it challenging for the immune system to maintain balance.

  • Some cells shifted towards a monocytic lineage, which may not be as effective in fighting off various infections.

The Bigger Picture – Implications for Recovery

These findings shed light on what happens after sepsis, making it clear that recovery is not just about getting through the initial infection. The long-term effects on blood cell production and functionality can leave survivors more susceptible to infections later on.

Opportunities for Therapies

Understanding how sepsis impacts the immune system opens doors for new treatments. There might be ways to "reset" the immune system through nutrition, medications, or other methods to help survivors regain a normal immune state.

Conclusion – A Call to Action

Sepsis isn't just a one-time event; it can change the landscape of the immune system in lasting ways. By learning more about these changes, we can work towards better support and treatment options for those who have fought through sepsis. So let's keep our eyes peeled and our immune systems ready; after all, nobody wants to run out of firefighters when the next infection comes knocking!

Original Source

Title: Sepsis induces long-term reprogramming of human HSPCs and drives myeloid dysregulation in sepsis survivors

Abstract: Sepsis is a life-threatening condition characterised by an overwhelming immune response and high fatality. While most research has focused on its acute phase, many sepsis survivors remain immunologically weakened leaving them susceptible to serious complications from even mild infections. The mechanisms underlying this prolonged immune dysregulation remain unclear, limiting effective interventions. Here, we analysed whether sepsis induced long-term "training" in hematopoietic stem and progenitor cells (HSPCs), imprinting changes that persist in their myeloid progeny. Peripheral blood analysis of 8 sepsis survivors, 12 patients with septic shock, and 10 healthy donors revealed a significant expansion of CD38+ progenitors in survivors, with increases in megakaryocyte-erythroid and granulocyte-monocyte progenitors, and reduced mature neutrophil counts. This shift suggests impaired granulopoiesis, favouring immature, immunosuppressive granulocytes. Differentiated macrophages from survivors HSPCs exhibited impaired metabolic pathways after lipopolysaccharide stimulation, with downregulation of tricarboxylic acid cycle and glycolysis genes, indicating altered immune metabolism. Pathway analysis revealed enhanced type-I interferon (IFN) and JAK-STAT signalling in survivors macrophages, reflective of potentially tolerance-prone reprogramming. Finally, exposing healthy donor HSPCs to IFN{beta} during macrophage differentiation reduced HSPC proliferation, increased apoptosis, and induced a metabolic shift towards glycolysis over mitochondrial respiration. Together, these findings suggest that sepsis induces lasting reprogramming in HSPCs leading to myeloid progeny with altered immune memory that might drive immune dysregulation in survivors. These data open avenues to explore potential targets to better manage long-term immune alterations in sepsis survivors. KEY POINTSO_LISepsis induces long-term alterations in HSPCs, leading to the expansion of immature progenitors and metabolic dysregulation of their progeny. C_LIO_LIType-I IFN signalling reprograms macrophage differentiation, affecting their metabolic function and reducing cell proliferation. C_LI

Authors: Marco De Zuani, Petra Lázničková, Marcela Hortová Kohoutková, Veronika Bosáková, Ivana Andrejčinová, Natália Vadovičová, Veronika Tomášková, Alexandra Mýtniková, Julie Štíchová, Tomáš Tomáš, Jiří Hrdý, Kristýna Boráková, Stjepan Uldrijan, Marcela Vlková, Vladimír Šrámek, Martin Helán, Kamila Bendíčková, Jan Frič

Last Update: 2024-12-17 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.12.14.628447

Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.14.628447.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles